CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 79 filers reported holding CYTOSORBENTS CORP in Q2 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $151,861 | +134290.3% | 42,301 | -8.1% | 0.05% | +15.6% |
| Q1 2023 | $113 | +76.6% | 46,050 | +11.8% | 0.04% | +73.1% |
| Q4 2022 | $64 | -99.9% | 41,200 | -2.4% | 0.03% | -21.2% |
| Q3 2022 | $57,000 | -38.0% | 42,200 | 0.0% | 0.03% | -36.5% |
| Q2 2022 | $92,000 | +84.0% | 42,200 | +170.5% | 0.05% | +147.6% |
| Q1 2022 | $50,000 | +212.5% | 15,600 | +316.0% | 0.02% | +320.0% |
| Q4 2021 | $16,000 | +60.0% | 3,750 | +212.5% | 0.01% | +25.0% |
| Q3 2021 | $10,000 | -89.1% | 1,200 | -97.2% | 0.00% | -92.3% |
| Q2 2020 | $92,000 | – | 42,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 1,772,000 | $13,379,000 | 1.58% |
| Sargent Investment Group, LLC | 856,315 | $6,465,000 | 1.53% |
| Avenir Corp | 1,366,549 | $10,317,000 | 0.82% |
| CM Management, LLC | 150,000 | $1,133,000 | 0.82% |
| Winning Points Advisors, LLC | 136,900 | $1,035,000 | 0.78% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,397,000 | 0.46% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,847,000 | 0.15% |
| Redmile Group, LLC | 1,304,369 | $9,848,000 | 0.15% |
| Granahan Investment Management | 1,003,546 | $7,577,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $265,000 | 0.14% |